InsidersTradesSigma
Follow the CalciMedica, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €19.6m. The latest transaction was reported on 29 June 2026 (Attribution). Among the most active insiders: Roberts Eric W. Every trade is openly available.
96
Insider Decl.
n/a
Thresholds
€3m
77 ops.
Buy Volume
€3,105
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CalciMedica, Inc. Buy (bullish), based on 2 analysts. Average price target: US$10.50.
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations96 total
1,182,621 sharesCommon StockSEC:0001189022-26-000002:0
248,972 sharesCommon StockSEC:0001267959-26-000003:0
Canonical exit: 23 Sept 2026 (T+90)
186,729 sharesCommon StockSEC:0001484729-26-000004:0
186,729 sharesCommon StockSEC:0001576244-26-000004:0
124,486 sharesCommon StockSEC:0001968793-26-000004:0
2,500 shares@ US$3.070.8% of flowCommon StockSEC:0001576244-25-000007:0
Canonical exit: 17 Dec 2025 (T+90)
3,400 shares@ US$2.67790.9% of flowCommon StockSEC:0001576244-25-000005:0
Canonical exit: 14 Dec 2025 (T+90)
5,000 shares@ US$3.121.6% of flowCommon StockSEC:0001576244-25-000003:0
Canonical exit: 11 Dec 2025 (T+90)
2,343 shares@ US$3.14880.8% of flowCommon StockSEC:0001415889-25-024256:0
Canonical exit: 8 Dec 2025 (T+90)
9,200 shares@ US$2.8632.9% of flowCommon StockSEC:0001415889-25-023364:0
Canonical exit: 26 Nov 2025 (T+90)
3,508 shares@ US$2.79281.1% of flowCommon StockSEC:0001415889-25-022850:0
Canonical exit: 19 Nov 2025 (T+90)
1,000 shares@ US$2.790.3% of flowCommon StockSEC:0001415889-25-022550:0
Canonical exit: 17 Nov 2025 (T+90)
9,563 shares@ US$2.819416.0% of flowCommon StockSEC:0001415889-25-022549:0
Canonical exit: 17 Nov 2025 (T+90)
5,076 shares@ US$2.89771.6% of flowCommon StockSEC:0001415889-25-022261:0
Canonical exit: 13 Nov 2025 (T+90)
1,584 shares@ US$2.5852.9% of flowCommon StockSEC:0001415889-25-022159:0
Canonical exit: 12 Nov 2025 (T+90)
1,000 shares@ US$3.6566.5% of flowCommon StockSEC:0001415889-25-020458:0
1,500 shares@ US$3.7750.6% of flowCommon StockSEC:0001415889-25-020164:0
Canonical exit: 20 Oct 2025 (T+90)
1,500 shares@ US$3.370.6% of flowCommon StockSEC:0001415889-25-020111:0
Canonical exit: 19 Oct 2025 (T+90)
1,000 shares@ US$3.400.6% of flowCommon StockSEC:0001415889-25-020052:0
Canonical exit: 19 Oct 2025 (T+90)
4,500 shares@ US$2.871.3% of flowCommon StockSEC:0001415889-25-019998:0
Canonical exit: 16 Oct 2025 (T+90)
2,000 shares@ US$2.880.7% of flowCommon StockSEC:0001415889-25-019997:0
Canonical exit: 16 Oct 2025 (T+90)
6,500 shares@ US$2.43231.8% of flowCommon StockSEC:0001415889-25-019822:0
Canonical exit: 12 Oct 2025 (T+90)
2,500 shares@ US$2.471.1% of flowCommon StockSEC:0001415889-25-019816:0
Canonical exit: 12 Oct 2025 (T+90)
5,000 shares@ US$1.60470.9% of flowCommon StockSEC:0001415889-25-019655:0
Canonical exit: 7 Oct 2025 (T+90)
1,000 shares@ US$1.85100.0% of flowCommon StockSEC:0001415889-25-019190:0
Canonical exit: 29 Sept 2025 (T+90)
25 of 96 declarations
关于 CalciMedica, Inc.
CalciMedica, Inc. 是一家生物制药公司，专注于开发与钙调节相关的疾病治疗方法。该公司在纳斯达克上市，股票代码为 XNAS。